More Facebook friends may mean longer life

Having more friends on social media can have benefits for patients—namely, being less likely to die in the next two years.

The Los Angeles Times reported on a new study that compared Facebook activity and mortality rates of registered voters in California. People who received many friend requests over a two-year span were less likely to die than those who did not.

While the benefits of social interactions on health have been known for years, some researchers had been worried that networks like Facebook could have the opposite effect.

“There was definitely a concern about this that the authors point to in motivating their research,” Michael Macy, a computational social scientist at Cornell University who was not involved in the study, said to the Times. “And, of course, their finding is that it’s just the opposite.”

Sending friend requests, however, didn’t have the same positive effects on mortality rates.

For more on the implications of this study and whether physicians need to start telling patients to get more Facebook friends, click on the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.